Fukun Chen

872 total citations
27 papers, 583 citations indexed

About

Fukun Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fukun Chen has authored 27 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Fukun Chen's work include Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Fukun Chen is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Fukun Chen collaborates with scholars based in China and United States. Fukun Chen's co-authors include Zhiping Feng, Pengjie Liu, Jialun Zhu, Juan Lv, Fei Hou, Chao Liu, Zhixian Yang, Conghui Yang, Long Chen and Yue Wang and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Frontiers in Immunology.

In The Last Decade

Fukun Chen

24 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fukun Chen China 14 332 228 125 111 99 27 583
Bingyin Shi China 14 389 1.2× 171 0.8× 211 1.7× 66 0.6× 72 0.7× 28 661
Jinchun Yan United States 13 466 1.4× 324 1.4× 211 1.7× 165 1.5× 47 0.5× 26 807
Jurriaan Brouwer‐Visser United States 12 239 0.7× 121 0.5× 170 1.4× 46 0.4× 74 0.7× 46 495
Sumi Yun South Korea 12 190 0.6× 150 0.7× 215 1.7× 119 1.1× 51 0.5× 25 469
David Barron United States 8 215 0.6× 120 0.5× 142 1.1× 229 2.1× 71 0.7× 13 559
Biao Liu China 17 276 0.8× 200 0.9× 176 1.4× 209 1.9× 52 0.5× 36 602
Songshan Feng China 15 234 0.7× 132 0.6× 90 0.7× 153 1.4× 194 2.0× 27 534
Jianfeng Sang China 12 459 1.4× 368 1.6× 130 1.0× 62 0.6× 97 1.0× 42 692
Xianchun Yan China 13 305 0.9× 161 0.7× 87 0.7× 64 0.6× 71 0.7× 27 569
Xinhai Wan United States 9 235 0.7× 119 0.5× 208 1.7× 185 1.7× 39 0.4× 10 503

Countries citing papers authored by Fukun Chen

Since Specialization
Citations

This map shows the geographic impact of Fukun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fukun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fukun Chen more than expected).

Fields of papers citing papers by Fukun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fukun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fukun Chen. The network helps show where Fukun Chen may publish in the future.

Co-authorship network of co-authors of Fukun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Fukun Chen. A scholar is included among the top collaborators of Fukun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fukun Chen. Fukun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Fukun, Haijuan Tang, Yaoyao Liu, et al.. (2025). Molecular characterization of EBV-associated primary pulmonary lymphoepithelial carcinoma by multiomics analysis. BMC Cancer. 25(1). 85–85. 4 indexed citations
2.
Chen, Fukun, et al.. (2025). Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs. Annals of General Psychiatry. 24(1). 10–10.
4.
Peng, Xiaoqi, Hongbo Zhao, Fei Hou, et al.. (2024). Biomarker Identification and Risk Prediction Model Development for Differentiated Thyroid Carcinoma Lung Metastasis Based on Primary Lesion Proteomics. Clinical Cancer Research. 30(14). 3059–3072. 1 indexed citations
5.
Chen, Fukun, et al.. (2024). Mesenchymal stem cells and ferroptosis: Clinical opportunities and challenges. Heliyon. 10(3). e25251–e25251. 16 indexed citations
7.
Liu, Li, et al.. (2023). Disulfidptosis-associated LncRNAs index predicts prognosis and chemotherapy drugs sensitivity in cervical cancer. Scientific Reports. 13(1). 12470–12470. 28 indexed citations
8.
Chen, Fukun, et al.. (2023). Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges. Cell Transplantation. 32. 4231222107–4231222107. 25 indexed citations
9.
Tang, Ming‐Jer, Wenliang Li, Jiayu Li, et al.. (2023). Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma. Frontiers in Oncology. 12. 993948–993948. 7 indexed citations
10.
Chen, Shi, et al.. (2023). Bone marrow mesenchymal stem cells inhibit ferroptosis via regulating the Nrf2-keap1/p53 pathway to ameliorate chronic kidney disease injury in the rats. Journal of Receptors and Signal Transduction. 43(1). 9–18. 5 indexed citations
11.
Xue, Zhengbo, Jian Yuan, Fukun Chen, et al.. (2022). Genome-wide association meta-analysis of 88,250 individuals highlights pleiotropic mechanisms of five ocular diseases in UK Biobank. EBioMedicine. 82. 104161–104161. 33 indexed citations
12.
Chen, Long, Fukun Chen, Conghui Yang, et al.. (2022). Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities. Frontiers in Immunology. 13. 871661–871661. 6 indexed citations
13.
Yuan, Jian, Tongyang Gong, Dandan Fan, et al.. (2021). Loss of grand histone H3 lysine 27 trimethylation domains mediated transcriptional activation in esophageal squamous cell carcinoma. npj Genomic Medicine. 6(1). 65–65. 14 indexed citations
14.
Chen, Yan, Fukun Chen, Juan Lv, et al.. (2021). Small activating RNA-activated NIS gene promotes 131I uptake and inhibits thyroid cancer via AMPK/mTOR pathway. Pathology - Research and Practice. 229. 153735–153735. 7 indexed citations
15.
Yuan, Jian, Fukun Chen, Dandan Fan, et al.. (2021). EyeDiseases: an integrated resource for dedicating to genetic variants, gene expression and epigenetic factors of human eye diseases. NAR Genomics and Bioinformatics. 3(2). lqab050–lqab050. 13 indexed citations
16.
Zhu, Jialun, et al.. (2021). circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis. Journal of Receptors and Signal Transduction. 42(3). 251–260. 12 indexed citations
17.
Lv, Juan, Fukun Chen, Chao Liu, et al.. (2020). Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway. Life Sciences. 256. 117925–117925. 47 indexed citations
18.
19.
Chen, Fukun, Shu-Ting Yin, Jialun Zhu, et al.. (2018). lncRNA DGCR5 acts as a tumor suppressor in papillary thyroid carcinoma via sequestering miR‑2861. Experimental and Therapeutic Medicine. 17(1). 895–900. 26 indexed citations
20.
Chen, Fukun, et al.. (2018). Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway. Cancer Biology & Therapy. 19(12). 1139–1152. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026